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*Mycobacterium chimaera* is a nontuberculous mycobacterial species within the *Mycobacterium avium* complex (MAC). The use of single genes such as the 16s rRNA or *rpo*B for species identification often misidentifies *M. chimaera* as the closely related MAC species *M. intracellulare* ([@B1], [@B2]). *M. chimaera* is an opportunistic environmental pathogen implicated in cardiovascular and pulmonary infections ([@B1], [@B3]). In health-care settings, the occurrence and spread of *M. chimaera* infections have increased in prevalence in recent years, including recent outbreaks that have been attributed to contaminated medical equipment ([@B4][@B5][@B6]). Despite the public health relevance of *M. chimaera*, only three draft genomes are publicly available, none of which is a complete genome ([@B7]). To improve our understanding of this emerging pathogen, we sequenced and report here the first complete genome of *M. chimaera*.

*M. chimaera* strain AH16, isolated from an 87-year-old male with suspected mycobacterial lung disease in O'ahu, Hawai'i, was identified using partial *rpoB* sequencing. The genome of *M. chimaera* AH16 was sequenced using Pacific Biosciences (PacBio) RSII single-molecule real-time (SMRT) technology. PacBio sequencing produced 243,370 reads (mean: 6,808 bp; min: 50 bp; max: 45,065 bp; \~262× genome coverage). The *de novo* genome assembly was performed using the Hierarchical Genome Assembly Process ([@B8]). The assembly was compared to other MAC genomes using Mauve version 2.3.1 ([@B9]). Genomic features were identified and annotated using the NCBI Prokaryotic Genome Annotation Pipeline ([@B10]).

The genome of *M. chimaera* AH16 consists of 4 scaffolds equaling 6,328,534 bp (5,851,561-bp chromosome; 437,456-bp plasmid; 25,007-bp plasmid; 14,510-bp plasmid) and a G+C content of 67.56%. A total of 4,926 coding sequences (CDSs) were predicted, including 3,161 CDSs (64.17%) with functional annotations and 1,765 CDSs (35.83%) annotated as hypothetical proteins. Our genome assembly contains 74 tRNAs, one ncRNA, and one rRNA cistron consisting of the 16S, 23S, and 5S rRNA genes.

Whole-genome alignments of *M. chimaera* AH16 and six MAC genomes revealed 511,189 variable single nucleotide polymorphisms (SNPs), including: 459,672 SNPs compared to *M. avium* subsp. *hominis suis* TH135; 64,709 SNPs compared to *M. intracellulare* ATCC 13950; 50,875 SNPs compared to *Mycobacterium* sp. MOTT 36Y; 49,805 SNPs compared to *M. yongonense* 05-0390^T^; and 49,524 SNPs compared to *Mycobacterium* sp. H4Y. Comparing the *M. chimaera* AH16 genome against the *M. avium* subsp. *hominis suis* TH135, *M. intracellulare* ATCC 13950, *M. yongonense* 05-0390^T^, *Mycobacterium* sp. MOTT 36Y, and *Mycobacterium* sp. H4Y genomes, the average nucleotide identities (ANIs) were 85.55%, 96.87%, 97.14%, 97.16%, and 97.22%, respectively. The limited SNP variation (0.78 to 7.26% of the *M. chimaera* AH16 genome) and ANI values observed between *M. chimaera* AH16 and MAC species suggests that the non--*M. avium* MAC species have limited genomic variation. Furthermore, intraspecies genome comparisons of *M. chimaera* AH16 to *M. chimaera* MCIMRL6, MCIMRL4, and MCIMRL2 (accession nos. LJHN00000000, LJHM00000000, and LJHL00000000) have 99.14%, 99.11%, and 99.18% ANIs, respectively, which are within the 95 to 96% cutoff for species boundaries ([@B11]).
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The genome sequence of *M. chimaera* AH16 is deposited in NCBI GenBank under the accession numbers [CP012885](http://www.ncbi.nlm.nih.gov/nuccore/CP012885) to [CP012888](http://www.ncbi.nlm.nih.gov/nuccore/CP012888).
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